TB diagnostic testing type
This indicator measures the proportion of people living with HIV who screen positive for TB symptoms who receive a recommended test for diagnosis of TB.
- People living with HIV should be screened for TB symptoms and, if found positive, be tested for TB.
- WHO recommends rapid-diagnostic molecular tests, for example, Xpert MTB/RIF, as the first test for diagnosis of TB among people living with HIV.
Number of people living with HIV and having TB symptoms who were tested using a rapid molecular test (for example, Xpert MTB/RIF) as a first test during the reporting period
Number of people living with HIV and who are screened for TB and found to have symptoms during the reporting period
For the numerator and denominator. Programme records (for example, laboratory register for smear microscopy and Xpert MTB/RIF, ART registers)
- Gender (male, female, transgender)
- Age (<15, 15+)
- Key populations (men who have sex with men, people living in prisons and other closed settings, people who inject drugs, sex workers, transgender people)
- Pregnant or breastfeeding women.
Additional recommendation for settings with robust electronic HIS, for example, EMRs:
- Disaggregation by detailed age (<18 month-4 years, 5-14, 15-19, 20-24, 25-49, 50+)
WHO Strategic Information Guidelines, 2020 (https://indicatorregistry.unaids.org/sites/default/files/9789240000735-eng.pdf)